Data processing: artificial intelligence – Knowledge processing system – Knowledge representation and reasoning technique
Reexamination Certificate
2006-08-29
2006-08-29
Vincent, David (Department: 2129)
Data processing: artificial intelligence
Knowledge processing system
Knowledge representation and reasoning technique
C706S048000, C706S020000, C707S793000
Reexamination Certificate
active
07099857
ABSTRACT:
A computer-implemented apparatus or method, or a software product, for generating a composite quantitative comparison of drug products based on multiple attributes of them. A set of name-attribute similarity scores are generated based on similarities among the names of selected target and reference drugs. A set of product-attribute similarity scores are generated based on similarities among product attributes of the selected target and reference drugs. A target drug confusability score is generated based on the confusability of the target drug as compared to a population of other drugs. The composite quantitative comparison is generated based on a composite of the name-attribute and product-attribute similarity scores, and the target confusability score. A set of one or more severity of confusion scores may also be included in the composite quantitative comparison. These scores are based on one or more indicators of the severity of the consequences to a patient of confusing the target and reference drugs so that, for example, the wrong drug is administered to the patient, or the correct drug is incorrectly administered. The name-attribute similarity scores may be generated based on orthographic, phonetic, and/or phonological analysis. The product-attribute similarity scores may be generated based on the drugs'strengths, indications, dosages, administration routes, manufacturers, pharmacological categories, storage requirements, colors, shapes, legal standing, trademark description, and/or other attributes. The composite quantitative comparison may include severity-weighted similarity scores or both similarity scores and severity of confusion scores. The severity of confusion indicators may include a therapeutic index and/or a contraindication index.
REFERENCES:
patent: 3923060 (1975-12-01), Ellinwood, Jr.
patent: 4382277 (1983-05-01), Glaser et al.
patent: 4384325 (1983-05-01), Slechta, Jr. et al.
patent: 4422158 (1983-12-01), Galie
patent: 4674066 (1987-06-01), Kucera
patent: 4688189 (1987-08-01), Hirata
patent: 4833610 (1989-05-01), Zamora et al.
patent: 5297039 (1994-03-01), Kanaegami et al.
patent: 5333317 (1994-07-01), Dann
patent: 5365455 (1994-11-01), Tibbetts et al.
patent: 5416696 (1995-05-01), Suzuoka
patent: 5701466 (1997-12-01), Yong et al.
patent: 5802508 (1998-09-01), Morgenstern
patent: 5845255 (1998-12-01), Mayaud
patent: 5854923 (1998-12-01), Dockter et al.
patent: 5898586 (1999-04-01), Jeatran et al.
patent: 5937400 (1999-08-01), Au
patent: 6009397 (1999-12-01), Siegel
patent: 6243501 (2001-06-01), Jamali
patent: 6529892 (2003-03-01), Lambert
patent: 2005/0027560 (2005-02-01), Cook
Lambert, B.: “Predicting look-alike and sound-alike medication errors”, Am J. Health-Syst Pharm, vol. 54, May 15, 1997, pp. 1161-1171.
U.S. Pharmacopeia, Appendix I: “Guiding Principles for Coining United States Adopted Names for Drugs”, USP Dictionary of USAN and international drug names, 1998, pp. 867-875.
Lively, S., et al.: “Spoken Word Recognition Research and Theory”, Handbook of Psycholinguistics, 1994, pp. 265-301.
Luce, P., et al.: “Similarity Neighborhoods of Spoken Words”, Word Frequency Effects, 1990, pp. 122-147.
Booring, D., Rph., PhD, “The Development and Adoption of Nonproprietary, Established, and Proprietary Names for Pharmaceuticals”, Drug Information Journal, vol. 31, 1997, pp. 621-635.
Hal, P.A.V.I et al.: “Approximate String Matching”, ACM Computing Surveys, vol. 12, No. 4, Dec. 1980, pp. 111-132.
Stephen, G.: “String Distance and Common Sequences”, String Searching Algorithms, Lecture Notes Series of Computing, vol. 3, pp. 39-87.
Cohen, M. “Drug product characteristics that foster drug-use-system errors”, Am J. Health-Syst Pharm, vol. 52, Feb. 1995, pp. 395-399.
Lambert, L., et al.: “Predicting and Preventing Drug Name Confusion Errors: A Summary of Findings”, Enhancing Patient Safety and Reducing Errors in Health Care, 1998, pp. 221-225, p. 215.
USP Quality Review—Use Caution—Avoid Confusion:, USP Practitioners' Reporting Network, May 1999, No. 6, pp. 1-4.
Luce, P. et al.: “Recognizing Spoken Words: The Neighborhood Activation Model”, Ear and Hearing, vol. 19, No. 1, Feb. 1998, pp. 1-36.
Monsell, S.: “The Nature of Locus of Word Frequency Effects in Reading”, Basic Processes in Reading, Visual Word Recognition, 1991, pp. 148-197.
Havens, L. et al.: “The Effect of Competition of Visual Duration Threshold and its Independence of Stimulus Frequency”, Journal of Experimental Psychology, 1963, vol. 65, No. 1, pp. 6-11.
Grainger, J. Dijkstar, T.: “Visual Word Recognition: Models and Experiments”, In: Dijkstra, T., de Smedt K, eds. Computational Psycholinguistics, 1996, pp. 139-165.
Grainger, J., Segui, J.: “Neighborhood frequency effects in visual word recognition: A comparison of lexical decision and masked identification latencies”, Perception & Psychophysics, 1990, pp. 191-198.
Zobel, J., Dart P.: “Phonetic String Matching: Lessons from Information Retrieval”, SIGIR96: Proceedings of the 19th Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, Switzerland, Aug. 18-22, 1996, pp. 166-172.
Lambert, B., et al.: “Similarity as a Risk Factor in Drug Name Confusion Errors: The Look-Alike (Orthographic) and Sound-Alike (Phonetic) Model”, Medical Care, in press, Mar. 1999, pp. 1-37.
Lambert, B., et al.: “Effects of Similarity of Pharmacists' Recall and Recognition of Drug Names”, Pharm Sci 1998, 1:1333.
Grainger, J. et al.: “On the role of competing word units in visual word recognition: The neighborhood frequency effect”, Perception & Psychophysics, 1989; 45:189-195.
Kohonen, T.: “Content-Addressable Memories”, Second Edition New York: Springer-Verlag, 1987, pp. 19-27.
Kane, S.D.: “Trademark Law: A Practitioner's Guide” Practicing Law Institute, 1997, pp. 7/2-7/23.
Baddeley, A.D.: “The articulary loop”, Working Memory, Oxford: Oxford University Press, 1986, pp. 75-107.
Lambert, Bruce L., “Automated Screening for Look-Alike and Sound-Aike Medication Errors,” presentation Jan. 8, 1998 Food and Drug Administration conference: “Minimizing Medical Product Errors: A Systems Approach.”
Executive Summary, “Minimizing Medical Product Errors: A Systems Approach,” Jan. 8, 1998 Food and Drug Administration conference.
Winslett, Marianne, et al., “Formal Query Languages for Secure Rational Databases”, ACM Transactions on Database Systems, vol. 19 No. 4, Dec. 1994, pp. 626-662.
BLL Consulting, Inc.
Caldwell Michael
Jagtiani & Guttag
Vincent David
LandOfFree
Multi-attribute drug comparison does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multi-attribute drug comparison, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multi-attribute drug comparison will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3642871